ribociclib,abemaciclib,palbociclib,dalpiciclib
eli lilly,pfizer,jiangsu hengrui pharmaceuticals,novartis
['breast', 'abema', 'palbo', 'dalpiciclib', 'dawna2', ' ribo']
at #esmo22 results from #dawna2 trial: #dalpiciclib is the 4th cdk4/6i after palbo, ribo and abema to demonstrate significant pfs improvement in hr+,her2-neg #breastcancer in first line. 
MD, Medical Oncologist????•Research Fellow at @JulesBordet Institute in Brussels???? Great interest in #BreastCancer and #ImmunoOncology